Your browser doesn't support javascript.
loading
Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.
Trinh, Trang D; Strnad, Luke; Damon, Lloyd; Dzundza, John H; Graff, Larissa R; Griffith, Laura M; Hilts-Horeczko, Alexandra; Olin, Rebecca; Shenoy, Samantha; DeVoe, Catherine; Wang, Lusha; Rodriguez-Monguio, Rosa; Gu, Tina M; Hampton, Scott R; Macapinlac, Brian Allan C; Yang, Katherine; Doernberg, Sarah B.
Affiliation
  • Trinh TD; Medication Outcomes Center, Department of Clinical Pharmacy, University of California, San Francisco School of Pharmacy, San Francisco, California.
  • Strnad L; Division of Infectious Diseases, Department of Medicine, Oregon Health and Sciences University School of Medicine, Portland, Oregon.
  • Damon L; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, California.
  • Dzundza JH; Division of Hospital Medicine, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, California.
  • Graff LR; Department of Pharmaceutical Services, University of California, San Francisco Health, San Francisco, California.
  • Griffith LM; Department of Nursing, University of California, San Francisco Health, San Francisco, California.
  • Hilts-Horeczko A; Department of Pharmaceutical Services, University of California, San Francisco Health, San Francisco, California.
  • Olin R; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, California.
  • Shenoy S; Hematology and Oncology Clinic, University of California, San Francisco Health, San Francisco, California.
  • DeVoe C; Division of Infectious Diseases, Department of Medicine, University of California School of Medicine, San Francisco, San Francisco, California.
  • Wang L; Division of Infection Prevention, Department of Quality, University of California, San Francisco Health, San Francisco, California.
  • Rodriguez-Monguio R; Medication Outcomes Center, Department of Clinical Pharmacy, University of California, San Francisco School of Pharmacy, San Francisco, California.
  • Gu TM; Department of Pharmaceutical Services, University of California, San Francisco Health, San Francisco, California.
  • Hampton SR; Department of Pharmacy, University of California, San Diego Health, San Diego, California.
  • Macapinlac BAC; Department of Pharmacy, Kaiser Permanente, Union City, California.
  • Yang K; Department of Clinical Pharmacy, University of California, San Francisco School of Pharmacy, San Francisco, California.
  • Doernberg SB; Division of Infectious Diseases, Department of Medicine, University of California School of Medicine, San Francisco, San Francisco, California.
Infect Control Hosp Epidemiol ; 42(9): 1090-1097, 2021 09.
Article in En | MEDLINE | ID: mdl-33487182
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Febrile Neutropenia Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Infect Control Hosp Epidemiol Journal subject: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Febrile Neutropenia Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Infect Control Hosp Epidemiol Journal subject: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Year: 2021 Document type: Article Country of publication: